Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
BPC-157 is not approved by Health Canada for any therapeutic indication
The compound was also investigated as PL14736 in early-phase IBD clinical work, as described in a 2008 paper by Klicek and colleagues in Journal of Pharmacological Sciences , though that clinical program was never completed or approved
Some estimate that 20% of cancer deaths actually result from cachexia [12]
The information available on our Czech Republic Direct Peptides website: is provided for educational purposes only
What distinguishes BPC-157 from other therapeutic peptides is its ability to migrate systemically to damaged tissues
US$ 21.67
US$ 27.95
US$ 25.34
US$ 27.89
